Hosted: Wednesday, October 12, 2016
Duration: 60 minutes
Cryoport’s Mark Sawicki, Ph.D., chief commercial officer, hosts an informational webinar that discusses the new technologies, capabilities and resources required for the successful commercialization of regenerative medicines, supported by the results from sponsored research on the impact of packaging choices used during clinical studies. In the webinar you will learn:
- The results of research comparing shipping under dry ice and liquid nitrogen (LN2) cold chain shipping conditions
- A real-world examination of shipping techniques on cell viability and resultant GP19 assay performance, a target of genetic alterations found in cancers
- Practical risk mitigation strategies for packaging, logistics, systems integration, condition monitoring and technology
